Connor, Clark & Lunn Investment Management Ltd. Teva Pharmaceutical Industries LTD Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 823,544 shares of TEVA stock, worth $14.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

823,544

Holding current value

$14.1 Million

% of portfolio

0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$15.81 - $18.96 $13 Million - $15.6 Million	823,544 New	823,544 $14.8 Million
Q1 2023 May 09, 2023	SELL	$8.36 - $11.37 $30,806 - $41,898	-3,685 Reduced 8.59%	39,233 $347,000
Q4 2022 Feb 10, 2023	BUY	$7.95 - $9.48 $341,198 - $406,862	42,918 New	42,918 $391,000
Q2 2021 Aug 12, 2021	SELL	$9.9 - $11.56 $3.42 Million - $3.99 Million	-345,263 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$10.34 - $12.81 $29.3 Million - $36.3 Million	-2,835,932 Reduced 89.15%	345,263 $3.98 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $1.57 Million - $2.02 Million	-182,881 Reduced 5.44%	3,181,195 $30.7 Million
Q3 2020 Nov 12, 2020	BUY	$8.57 - $12.69 $15.1 Million - $22.3 Million	1,759,561 Added 109.66%	3,364,076 $30.3 Million
Q2 2020 Aug 13, 2020	BUY	$8.12 - $13.12 $8.83 Million - $14.3 Million	1,087,898 Added 210.58%	1,604,515 $19.8 Million
Q1 2020 May 13, 2020	BUY	$6.69 - $13.45 $3.46 Million - $6.95 Million	516,617 New	516,617 $4.64 Million
Q2 2019 Aug 07, 2019	SELL	$8.12 - $15.72 $6.81 Million - $13.2 Million	-838,120 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$15.58 - $20.01 $21.4 Million - $27.5 Million	-1,373,412 Reduced 62.1%	838,120 $13.1 Million
Q4 2018 Feb 12, 2019	BUY	$14.59 - $23.84 $3.38 Million - $5.51 Million	231,332 Added 11.68%	2,211,532 $34.1 Million
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $1.53 Million - $1.87 Million	72,875 Added 3.82%	1,980,200 $42.7 Million
Q2 2018 Aug 02, 2018	SELL	$16.77 - $24.71 $141,287 - $208,181	-8,425 Reduced 0.44%	1,907,325 $46.4 Million
Q1 2018 May 14, 2018	BUY	$16.68 - $22.07 $32 Million - $42.3 Million	1,915,750 New	1,915,750 $32.7 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Teva Pharmaceutical Industries LTD Transaction History